Navigation Links
/C O R R E C T I O N -- Rosetta Genomics Ltd/

ability to obtain coverage and payment from health plans and payers for diagnostic and therapeutic products applying Rosetta's technology and Rosetta's short operating history; as well as those risks more fully discussed under "Key Information - Risk Factors" in Rosetta's Annual Report on Form 20-F for the year ended December 31, 2006 on file with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of today and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.


(A development stage company)


U.S. dollars in thousands

March 31, December 31,

2008 2007




Cash and cash equivalents $ 9,511 $ 13,590

Short-term bank deposits 114 112

Marketable securities 8,964 8,251

Other accounts receivable and prepaid

expenses 405 297

Total current assets 18,994 22,250




Total assets $ 22,594 $ 26,038



SOURCE Rosetta Genomics Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
(Date:7/22/2014)... 22, 2014 Holomic is expanding ... debut of its fluorescent immunoassay reader, the HRDR-300, ... meeting in Chicago, July 28-31, 2014. Available in ... the HRDR-300 is a highly sensitive, low-cost fluorescent ... fluorescent lateral flow immunoassays with high sensitivity and ...
(Date:7/22/2014)... Biofeedback – When a behavioral problem ... medication to best treat it can become a matter ... electroencephalography (EEG) can help predict which medicine will offer ... adverse drug events. , The article “Medication Prediction ... issue of the journal Biofeedback offers evidence that quantitative ...
(Date:7/22/2014)... 22, 2014 Dr. Williams says, “Bush ... have recognized that the greatest health care system in ... often needlessly deadly while trying to serve the public. ... seeking to transform an enormous system that none of ... in his continuing series of Open Letters ( ...
(Date:7/21/2014)... (PRWEB) July 21, 2014 With ... simple programming, the new Cole-Parmer® Digital Gear ... is easy to operate for automated process applications. ... hands-free dispensing. The batch count function counts down ... or totalizer tracks amount dispensed across multiple cycles. ...
Breaking Biology Technology:Holomic to Debut HRDR-300 Fluorescent Immunoassay Reader at the AACC 2014 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 2Analyzing Brain Patterns with EEG Can Help Predict Effective Use of Medication 3Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2New Easy-View Cole-Parmer Digital Gear Pump Drive Makes Performance Monitoring Effortless 2
... NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical company ... that it is scheduled to present,on Wednesday, April ... Conference. Anthony DiTonno, President and Chief Executive,Officer, will ... be available to respond to questions., ...
... (Amex: IMA ), a global leader in rapid ... quarter,ended March 31, 2008., In the first quarter ... compared to net revenue of $159.0 million in the ... to increased,product and service revenue in our Professional Diagnostics ...
... 2007, artificial disc and dynamic stabilization,nonfusion segments skyrocketed, according to ... ... WALTHAM, Mass., April 24 Millennium Research Group,s,(MRG) US Spine ... nonfusion technologies. Rising patient and surgeon,awareness and new product releases ...
Cached Biology Technology:NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference 2NeurogesX to Present at the 2008 Morgan Stanley Global Healthcare Unplugged Conference 3Inverness Medical Innovations Announces First Quarter 2008 Results 2Inverness Medical Innovations Announces First Quarter 2008 Results 3Inverness Medical Innovations Announces First Quarter 2008 Results 4Inverness Medical Innovations Announces First Quarter 2008 Results 5Inverness Medical Innovations Announces First Quarter 2008 Results 6Inverness Medical Innovations Announces First Quarter 2008 Results 7Inverness Medical Innovations Announces First Quarter 2008 Results 8Inverness Medical Innovations Announces First Quarter 2008 Results 9Inverness Medical Innovations Announces First Quarter 2008 Results 10Adoption of Spinal Nonfusion Technologies Doubled in One Year 2
(Date:7/22/2014)... world-famous vacation spot with natural tourism resources, a recent study ... Institute of Geoscience and Mineral Resources (KIGAM) indicated that there ... was evident 5,000 years ago. That is the first time ... of a volcano 5,000 years ago in the inland part ... peninsula. , The research team led by Dr. Jin-Young Lee ...
(Date:7/22/2014)... type of immune cell widely believed to exacerbate ... and multiple sclerosis (MS), can actually protect the ... slow the progression of neurodegenerative diseases, according to ... journal Nature Communications . , The research ... the Department of Neurosciences at Cleveland Clinic,s Lerner ...
(Date:7/21/2014)... a professor of entomology and cooperating faculty ... the University of California, Riverside, has been awarded the ... of Chemical Ecology ( ISCE ). , Awarded first ... the society,s highest honor. It is awarded annually to ... the study of chemicals that mediate interactions between living ...
Breaking Biology News(10 mins):Jeju Island is a live volcano 2Cleveland Clinic researchers discover neuroprotective role of immune cell 2UC Riverside entomologist receives international honor for chemical ecology contributions 2
... to find ways to get more energy out of the sun. ... carbon dioxide and then convert it to oxygen and sugars. The ... throughout the plant like that sweet corn we look for ... we use is not as efficient as we would like. Now ...
... birds baked in a pie" but wait, one has blue-gray ... know there is one more species of black shrike in the ... Gary Voelker has his way, he,ll soon be studying the bird,s ... its native habitat. The bird Laniarius willardi , is ...
... obesity and exposed to passive smoking are more likely to ... evidence of elevated levels of nucleated red blood cells in ... Food Safety, Nutrition and Public Health . Pediatrician Abd ... there and at Cairo University, Egypt, have found that obesity ...
Cached Biology News:Frogs, foam and fuel: University of Cincinnati researchers convert solar energy to sugars 2African bird discovery proves there is something new under the sun 2Obesity and passive smoking reduce oxygen supply to unborn baby 2
Mouse polyclonal antibody to QPRT - quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating))...
... Protein Extraction Reagent is a ... that means no scraping, no ... With M-PER Reagent, rapid lysis ... at room temperature, yielding 25% ...
... The FailSafe™ PCR System is the ... the first time and every time. It ... regardless of the source or the property ... EPICENTRE's FailSafe™ PCR Enzyme Mix, a unique ...
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
Biology Products: